Flexible single-use manufacturing technologies at an advanced global site

From cell-line development and formulation to analytical services and commercial cGMP manufacturing, Bora now provides tailored development and manufacturing services to biologics developers end-to-end. With operations in newly acquired Taiwan facility, Bora has the capability to deliver high-yield processes and the program management needed to launch even the most challenging molecules successfully. 


Cell Engineering – Developing protein therapeutics is difficult because they are highly complex molecules that are grown by living cells cultured and cultivated in a precise, reproducible fashion. At Bora Biologics, we have mastered the art and science of cell engineering, cell culture, and protein purification.

Key Features 
    • Segregated USP/DSP
    • 2 x 500L bioreactors
    • Gowning facilities
    • Separated post viral processing
    • Clean utility systems (WFI/CS/CA)
    • HVAC systems and controls

Platform – As a top CDMO, we have a platform approach to developing biologics that allows us to perform all activities needed to transform biologics from concept to commercial product in-house.

Facility capabilities
    • Segregated upstream and downstream processing areas
    • Segregated media buffer preparation and holding areas
    • A two-suite purification area for pre-/post-viral processing and bulk filling
Robust biologics capabilities end-to-end, designed to accommodate biopharma’s unique needs

Our end-to-end solutions for biologics include cell-line and process development, analytics and formulations development, as well as full cGMP manufacturing and drug product filling and finishing services.